Welcome to BRAINZWAYZ, where we combine advanced, hands-on expertise with cutting-edge technology to help shape the future of clinical trials. In today’s fast-moving world, artificial intelligence is making waves in every industry—and life sciences is no exception. But at BRAINZWAYZ, we believe that technology is only as powerful as the way it’s applied. That’s why we focus on smarter AI-driven patient recruitment and trial management solutions that don’t just look good on paper, but work efficiently in practice. We design strategies that simplify processes, ease the burden on sites, and ensure smooth, scalable operations—keeping your trials on track, on budget, and ahead of schedule. But we don’t stop there. At BRAINZWAYZ, we partner with biotech executives to provide strategic consulting that helps you navigate critical decisions, from selecting the right CRO to expanding into new markets. Imagine a world where clinical trials are not a labyrinth of complexities, but a streamlined pathway to discovery and innovation, What if the challenges that typically slow down the start of each trial could be transformed into opportunities for enhanced efficiency and efficacy ? what if you could control your timelines without sacrificing quality ? these questions sparked a journey that has spanned over two decades, leading to breakthroughs in how we conduct clinical trials leading to the creation of BRAINZWAYZ

¾CRO) / Pharma Trial Runners (USA CRO / Ophtalmology) Troya Consultanting France

Report to the VP of Clinical Operations/Chief Medical Officer and daily collaborate with: VP Regulatory affairs/Director of Manufacturing/Chief Financial Officer/QA lead /Director of contracting & legal affairsResponsible for the PM and operational delivery of ABIVAX clinical studies :•Hepatitis B therapeutic Vaccine/HIV Vaccine : Asia (11 countries)/Phases 2-3•Protocols/IBs conception•CROs/Vendors : identification, evaluation and selection (12 CROs /8 vendors evaluated)•Budgets and contracts management : forecasting/negotiations/legal review/templates creation and review/risk management/liaison with legal consultants/reporting•Performance review vs. timelines : ABIVAX board/CROs / vendors•Key opinion leaders (ASIA) identification and management (F2F)•DSMB members identification and contracting•Investigators Meeting and CRAs training : ASIA/2 meetingsInternal responsibilities (non-study specific):•Maintaining consistency between company’s initiatives (introduction to stock market)/ Operational, financial objectives and risk management vs. timing•Participating in ABIVAX creation : merging of 3 biotechs•Training/mentoring : Junior PM/QA lead/Contract specialist/Director clinical•SOPs /WIs/Templates and Job descriptions : from draft to finalization for each position

Global PM : Pediatric Epilepsy Program (4 studies ) : Strategy set up and conduct •Overall PM responsibility •Countries/sites identification strategy development : Pediatric Sites •Contracting strategy development: Fixed Price vs. classical Work Order •Study plans development : including budget management •Vendors selection and Management : ECG / Lab / PK / CRO (Japan) /IXRS and e-Diary Global PM : Pain in Osteoarthritis ( 1 study; phase II ; 20 sites in Europe) •Overall PM responsibility (full services) •Consulting for compound development plan (Phase II design vs. Phase III) •Protocol amendment and study re-start : new study design proposal •Vendors Management : ePRO; IVRS; IP and Central lab AD /Global PM : Rheumatology ( 3 studies and 3 regions ) •Overall Program Management responsibilities in Rheumatology and Neurology:3 global trials from an international sponsor to CRO across 3 regions •Overall accountability in managing the operational transfer as well as the in monitoring service lines performance •Budget/ Work Orders management AD PM / Global lead : Influenza Vaccine Program : ( 3 studies Europe Phase 2) •Team members selection and BID defense preparation •Risk identification and management (Timelines/Set up related risks)

Associate Project Manager : July 2006 – September 2007- Phase III international study in late Parkinson’s Disease ( 14 countries in Europe, USA and Asia-Pacific)- Phase III trial in asthma (6 countries in Europe)Global Project Manager: September 2007-September 2010-Phase III international program in Acute Ischemic Stroke (2 studies):•Europe, USA (38 sites), Latin America and Asia pacific •Coordination, management, team leads - Phase III international study in Early Parkinson’s Disease:•Europe (13 countries), USA (15 sites), Africa (1 country) and Asia-pacific (4 countries)Regional Clinical Operations/Business Development Manager, Maghreb : September 2006 – December 2011•Development of Quintiles’ Operational services in North Africa: Principal Manager•Management Group, and finance Executive director an office head•Development of the expansion strategy (Business vs. Timelines vs. Operational requirements and Risk management)•Identification and selection of local partner : Audits / contracting agreements and monitoring the delivery•Project Managing facilitating the launch of all trials starting in North Africa (Proposals BID, follow up and close-out)•Main and unique point of contact for competent authorities, Ecs Directors and KOLs.•Creation and management of the “Maghreb” Clinical Operations department in 2011: Specific SOPs Development•Set-up of a quality/audit plan focusing on mid and long term improvementClinical Research Associate ( including 9 month as customer managed CRA): January 2005-July 2006•Site Management and Monitoring activities in numerous Phases (1-2-3 and 4)•11 international studies in (AECB, Influenza vaccine, Type 1 and 2 Diabetes , Poly rheumatoid Arthritis, Heart failure, Chronic rhinitis, Abdominal obesity and cardiovascular outcomes, Chronic sinusitis